 Nabriva Therapeutics plc NASDAQ:NBRV Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Dan Dolan - Chief Financial Officer Ted Schroeder - Chief Executive Officer Christine Guico-Pabia - Chief Medical Officer Conference Call Participants Carl Byrnes - Northland Capital Markets Thomas Yip - HC Wainwright Operator Good afternoon, ladies and gentlemen, and welcome to the Nabriva Therapeutics First Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. 